Kimberly-Clark, a global health and hygiene company and I-Flow, a healthcare company that develops and markets low-cost drug delivery systems and products for post-surgical pain relief and surgical
Cornerstone Pharmaceuticals (Cornerstone) has included cancer research scientist, Robert Weinberg, a founding member of the Whitehead Institute for Biomedical Research and a Professor of Biology at MIT, in
Ipsen and Braintree Laboratories have signed an agreement for the exclusive manufacturing, marketing and distribution rights of the latter’s proprietary formulation – BLI-800, in colonic cleansing before colonoscopy
Stem Cell Therapy’s to be subsidiary, Histostem has been awarded US Patent Number 7,582,477 B2, entitled: “Method of Isolating and Culturing Mesenchymal Stem Cell Derived from Cryopreserved Umbilical
Actelion has reported that the selective S1P1 receptor agonist ACT-128800/ RG3477 has achieved an important clinical milestone. Actelion’s selective S1P1 (Sphingosine-1-phosphate) receptor agonist has entered into a phase
Vivante GMP Solutions (Vivante) has completed process optimisation activities related to the upcoming production of a GMP clinical lot of an Oxford University adenovirus-based malaria vaccine. Reportedly, the
Spectrum Pharmaceuticals (Spectrum) has received a Complete Response Letter from the FDA regarding its supplemental New Drug Application (sNDA) for Fusilev (levoleucovorin) for injection. It is intended for
Pieris has reported continued progress in the development of its lead therapeutic program for the clinic. Under its manufacturing agreement with Wacker Biotech, Pieris has completed the first
MediGene has completed patient enrollment in its randomised phase II trial of EndoTAG-1, for the treatment of triple receptor-negative breast cancer. Results will be available as scheduled in
Locus Pharmaceuticals (Locus) has entered into a research collaboration with Novartis. As per the deal, Locus will collaborate with Novartis to discover novel chemotypes on targets of interest
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.